Illustration: Tiffany Herring/Axios
Medline raised $6.3 billion in its IPO, valuing the company at roughly $39 billion.
Why it matters: The biggest IPO since 2021 wasn't for a flashy AI darling but a medical supply company — a reminder that markets still reward stability.
